Mbx Biosciences
Clinical trials sponsored by Mbx Biosciences, explained in plain language.
Biotech developing peptide therapies for endocrine and metabolic disorders.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Weekly shot could free hypoparathyroidism patients from daily pills
Disease control Recruiting nowThis Phase 3 trial tests whether a once-weekly injection of canvuparatide (MBX 2109) can help adults with hypoparathyroidism reduce their daily calcium and vitamin D supplements while keeping blood calcium in a healthy range. The study includes 160 participants who will receive e…
Phase: PHASE3 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New obesity drug MBX 4291 enters first human safety trial
Disease control Recruiting nowThis early-stage study is testing an experimental drug, MBX 4291, in 124 adults with obesity. The main goal is to check the drug's safety and how the body processes it. Participants will receive either the drug or a placebo as a shot under the skin, and researchers will monitor f…
Phase: PHASE1 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC